These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 18752631)

  • 21. [Ribavirin: a new drug in the treatment of chronic hepatitis C].
    Salmerón J
    Gastroenterol Hepatol; 1997; 20(7):363-5. PubMed ID: 9377236
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thrombocytopenia in HCV infection. Natural interferon as an alternative therapy].
    Krzowska-Firych J; Modrzewska R; Kiciak SG
    Przegl Epidemiol; 2007; 61(4):771-6. PubMed ID: 18572510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C].
    Zeuzem S
    Dtsch Med Wochenschr; 1999 May; 124(20):636-42. PubMed ID: 10370387
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety of chronic hepatitis C treatment in hemophilic patients.
    Husa P; Roznovsky L; Smejkal P; Husova L; Penka M; Dite P
    Hepatogastroenterology; 2005; 52(65):1541-4. PubMed ID: 16201114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Steroids, interferon-alpha and ribavirin treatment of cryoglobulinemic glomerulonephritis concurrent with HCV infection].
    Guarnieri A; Marazzi F; Giorgi MP; Canepari G; Pino C; Moggia E; Manca A; Ghezzi PM
    G Ital Nefrol; 2002; 19(1):79-81. PubMed ID: 12165950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
    Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
    Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy for hepatitis C infection.
    Liang TJ
    N Engl J Med; 1998 Nov; 339(21):1549-50. PubMed ID: 9819457
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis C treatment of veterans with psychiatric illness.
    Rifai MA; Loftis JM; Hauser P
    Am J Gastroenterol; 2006 Mar; 101(3):673-4; author reply 674-5. PubMed ID: 16542298
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatitis C in drug addicts: access and treatment compliance].
    Sarmento E Castro R; Valente C; Ramos JP; Almeida JR; Marinho RT; Branco T; Andrade S; Macedo A
    Acta Med Port; 2011 Dec; 24 Suppl 2():483-92. PubMed ID: 22849938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus infection in heart transplantation: is ventricular assist device therapy an option?
    Rajagopalan N; Hoopes CW; Rosenau J
    Transplantation; 2013 Aug; 96(4):e23-4. PubMed ID: 23958885
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis C Virus Treatment and Injection Drug Users: It Is Time to Separate Fact From Fiction.
    McCance-Katz EF; Valdiserri RO
    Ann Intern Med; 2015 Aug; 163(3):224-5. PubMed ID: 26120801
    [No Abstract]   [Full Text] [Related]  

  • 32. [Management of hepatitis C among drug user patients].
    Moussalli J; Melin P; Wartelle-Bladou C; Lang JP
    Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S51-5. PubMed ID: 17965636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C.
    Rowan PJ; Tabasi S; Abdul-Latif M; Kunik ME; El-Serag HB
    J Clin Gastroenterol; 2004 Jul; 38(6):530-4. PubMed ID: 15220690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C treatment in drug users: perception versus evidence.
    Sylvestre D
    Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):129-30. PubMed ID: 16394792
    [No Abstract]   [Full Text] [Related]  

  • 35. Expanding the Scope of Integrated Behavioral Health Care for Patients With Hepatitis C Virus.
    Pyne JM
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):2015-6. PubMed ID: 25952310
    [No Abstract]   [Full Text] [Related]  

  • 36. Barriers to Hepatitis C Treatment and Interest in Telemedicine-Based Care Among Clients of a Syringe Access Program.
    Loy DE; Kamis K; Kanatser R; Rowan SE
    Open Forum Infect Dis; 2024 Mar; 11(3):ofae088. PubMed ID: 38464492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C cascade of care among people who inject drugs in Vancouver, Canada.
    Young S; Wood E; Milloy MJ; DeBeck K; Dobrer S; Nosova E; Kerr T; Hayashi PhD K
    Subst Abus; 2018; 39(4):461-468. PubMed ID: 29949450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing a community HCV service: project ITTREAT (integrated community-based test - stage - TREAT) service for people who inject drugs.
    Hashim A; O'Sullivan M; Williams H; Verma S
    Prim Health Care Res Dev; 2018 Mar; 19(2):110-120. PubMed ID: 29199921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
    Cunningham EB; Hajarizadeh B; Dalgard O; Amin J; Hellard M; Foster GR; Bruggmann P; Conway B; Backmund M; Robaeys G; Swan T; Marks PS; Quiene S; Applegate TL; Weltman M; Shaw D; Dunlop A; Bruneau J; Midgard H; Bourgeois S; Thurnheer MC; Dore GJ; Grebely J;
    BMC Infect Dis; 2017 Jun; 17(1):420. PubMed ID: 28610605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Australasian Hepatology Association consensus guidelines for the provision of adherence support to patients with hepatitis C on direct acting antivirals.
    Richmond JA; Sheppard-Law S; Mason S; Warner SL
    Patient Prefer Adherence; 2016; 10():2479-2489. PubMed ID: 28008234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.